摘要:FDA批准肺炎链球菌13价结合疫苗(Prevnar13),用于50岁以上人群预防肺炎和由肺炎链球菌入侵引起的疾病。此疫苗的新用途是由快通道审批通过的。美国、欧洲对50岁以上接受此疫苗或23价肺炎链球菌疫苗纽莫法23(Pneumovax23)的随机、多中心、6000人的研究资料统计显示,
注:因版权方要求,不能公开全文,如需全文,请咨询杂志社
热门期刊服务
Journal of Hydrodynamics Journal of Huazhong University of Science and Technology The Journal of China Universities of Posts and Telecommunications Journal of Genetics and Genomics Journal of Iron and Steel Research Journal of Systems Science and Complexity World Journal of Gastroenterology Journal of Computer Science and Technology Applied Mathematics:A Journal of Chinese Universities International Journal of Minerals Metallurgy and Materials International Journal of Mining Science and Technology Journal of Systems Science and Systems Engineering